Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$28.84 - $38.92 $1,672 - $2,257
-58 Reduced 93.55%
4 $0
Q2 2022

Jul 13, 2022

BUY
$33.25 - $45.11 $1,130 - $1,533
34 Added 121.43%
62 $2,000
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $129 - $172
-3 Reduced 9.68%
28 $1,000
Q3 2021

Oct 29, 2021

SELL
$52.8 - $60.32 $105 - $120
-2 Reduced 6.06%
31 $2,000
Q2 2021

Aug 06, 2021

BUY
$51.29 - $59.15 $256 - $295
5 Added 17.86%
33 $2,000
Q4 2020

Feb 09, 2021

BUY
$35.18 - $43.52 $633 - $783
18 Added 180.0%
28 $1,000
Q2 2020

Aug 10, 2020

BUY
$31.07 - $44.74 $310 - $447
10 New
10 $0
Q1 2020

May 05, 2020

SELL
$22.46 - $42.24 $404 - $760
-18 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$38.23 - $47.43 $305 - $379
-8 Reduced 30.77%
18 $1,000
Q1 2019

May 01, 2019

BUY
$41.26 - $58.35 $453 - $641
11 Added 73.33%
26 $1,000
Q3 2017

Oct 27, 2017

BUY
$24.5 - $31.1 $367 - $466
15
15 $0

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.